Broken String Biosciences Unveils Catalyst Program to Accelerate Gene Editing Therapy Development Broken String Biosciences a leader in advancing gene editing safety, has officially launched its Catalyst Early Access Program…
Merck Begins Phase 3 Trial of Zilovertamab Vedotin for DLBCL Treatment DLBCL Treatment Merck known as MSD outside the United States and Canada, has officially announced the initiation of waveLINE-010,…
Know Labs Technology Licensing (KTL) Announces Official Client Partnership Know Labs is pleased to announce the official launch of its structured client engagement process for Know Labs Technology Licensing (KTL),…
GoodRx the leading prescription savings platform in the United States, has announced the appointment of Christopher A. McGinnis as its new Chief Financial Officer (CFO), effective February 4, 2025. McGinnis,…
Onc.AI Secures FDA Breakthrough Device Designation for AI-Powered CT Response Model Onc.AI, FDA a pioneering digital health company specializing in AI-driven oncology clinical management solutions, has achieved a significant milestone…
Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital, and Pharmascience Announce Exit from Pharmaceutics International, Inc. A consortium of investors, including Pharmascience Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital,…
Dr. Hong Jiang: Advancing Immunology from Scientific Breakthroughs to Clinical Applications Dr. Hong Jiang, MD, PhD, has been recognized in Marquis Who’s Who for her outstanding contributions to immunology and…
Claxton Copeland III Recognized for Excellence in Clinical Research Claxton Copeland III has been selected for inclusion in Marquis Who’s Who, a prestigious recognition that highlights individuals based on their…
Marquis Cheryl Custard: A Pillar of Excellence in Research and Development Cheryl Custard has earned a prestigious spot in Marquis Who’s Who , a recognition reserved for individuals who demonstrate…
Prolong Pharmaceuticals to Present Preliminary Phase 1 Data for PP-007 in AIS at 2025 ISC Phase 1 Data Prolong Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company, is poised to make a…
Announces Cencora Reports Strong Fiscal 2025 First Quarter Results, Expects Continued Growth and Strategic Expansion Announces Cencora has announced its results for the first quarter of fiscal year 2025, reporting…
New Breast Imaging Legislation Set to Benefit Thousands Across Pennsylvania Breast Imaging Susan G. Komen®, the world’s leading breast cancer organization, has recently praised Representative Gina Curry (D–Delaware) for her…